「th」の検索結果
186件：96～100件目を表示
-
Company Profile | About Senju | SENJU Pharmaceutical
6-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Managin...
https://www.senju.co.jp/english/about/outline.html -
千寿製薬株式会社
ASE August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and S...
http://www.senju.co.jp/english/ -
お知らせ | 千寿製薬株式会社
2026年08月20日 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） 2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700（PD...
https://www.senju.co.jp/chinese/news/ -
Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Sen...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
Company Profile | About Senju | SENJU Pharmaceutical
6-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Managin...
http://www.senju.co.jp/english/about/outline.html